Cancro endometriale avanzato, dostarlimab più chemio in prima linea ritarda la progressione
#Advanced #endometrial #cancer #dostarlimab #chemo
“PharmaStarTV”
There is very important news for women who have advanced or recurring endometrial cancer. Indeed, they have just been presented at the Society of Gynecologic Oncology (SGO) Annual Meeting, in Tampa, Florida, and also at the March Virtual Plenary of the…
source